← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2008Last known activity
Nov 7, 2018
Timeline
2000s
- Jun 1, 2002
Acucela Inc.— Founded
Drugs by trial phase (4 distinct, 12 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT03772665Lead sponsorPhase 3Nov 7, 2018
- NCT03772665Study directorPhase 3Nov 7, 2018
- NCT03033108Study directorPhase 2Jan 1, 2017
- NCT03033108Lead sponsorPhase 2Jan 1, 2017
- NCT02753400Study directorPhase 2Apr 1, 2016
- NCT02753400Lead sponsorPhase 2Apr 1, 2016
- NCT02130531Study directorPhase 1Apr 1, 2014
- NCT02130531Lead sponsorPhase 1Apr 1, 2014
- NCT01802866Study directorPhase 2/Phase 3Feb 1, 2013
- NCT01802866Lead sponsorPhase 2/Phase 3Feb 1, 2013
- NCT01632137Study directorPhase 3Jun 1, 2012
- NCT01632137Lead sponsorPhase 3Jun 1, 2012
- NCT01410188Lead sponsorPhase 1/Phase 2Sep 1, 2011
- NCT01410188Study directorPhase 1/Phase 2Sep 1, 2011
- NCT01057147Study directorPhase 2Feb 1, 2010
Details
- Founded
- Seattle, WA, US Jun 1, 2002
- Last known activity
- Nov 7, 2018